Evidence map›Paper›PMID 21722573›Full record

ArticleJournal of diabetes science and technology2011

Interstitial fluid physiology as it relates to glucose monitoring technologies: symposium introduction.

Natalie A Wisniewski, Uli Klueh, Julie Stenken

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Natalie A WisniewskiMedical Device Consultancy, San Francisco, California, USA.
Uli Klueh
Julie Stenken

Funding

Quantitative Biocompatibility of Implanted MaterialsR01EB001441 · NIBIB · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI STENKEN, JULIE A · 2003 to 2010
$1.9M
Inflammation and Glucose Sensor FunctionR01DK074817 · NIDDK · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KREUTZER, DON · 2007 to 2009
$1.1M
NIBIB NIH HHS EB 001441NIDDK NIH HHS DK074817
6 · The paper itself

Abstract

Nearly all commercially available glucose sensors share the subcutaneous interstitial fluid (ISF) compartment as their preferred implantation site. However, ISF physiology as it relates to glucose sensors is not well understood. This special symposium titled "Interstitial Fluid Physiology as It Relates to Glucose Monitoring Technologies" is intended to help to bridge the gap in our understanding. This symposium is intended to foster a greater understanding of biological factors that impact the success of implantable glucose monitors and to inspire additional research in the area of ISF physiology as it relates to glucose sensing. Recognition that sensor designers need to have an intimate understanding of the biological environment in which their sensor will reside is emphasized. The symposium is published in two parts, with part I published in September 2010 and part II published in May 2011. All articles published in this symposium are summarized herein.

Indexed as

AnimalsBiosensing TechniquesBlood GlucoseBlood Glucose Self-MonitoringBrain InjuriesDiabetes MellitusDisease Models, AnimalExtracellular FluidHomeostasisHumansMicrodialysisSkinBlood Glucose

Identifiers

PMID21722573
PMCPMC3192624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.